$2.130
+0.010 (+0.47%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Grace Therapeutics, Inc (GRCE) Moving Averages Convergence Divergence (MACD) indicator is -0.03, suggesting GRCE is Strong sell.
Grace Therapeutics, Inc (GRCE) 20-Day simple moving average is 2.14, while Grace Therapeutics, Inc (GRCE) share price is $—, making it Sell.
Grace Therapeutics, Inc (GRCE) 60-Day simple moving average is 2.26, while Grace Therapeutics, Inc (GRCE) share price is $—, making it Sell.
Technical Analysis for GRCE
AI Technical GRCEAs of 2026-08-29, the technical board for Grace Therapeutics, Inc (GRCE) reads strong sell: 1 indicators are flashing buy, 8 are indicating sell, and 4 are neutral. Price at $2.13 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 45.39, MACD stands at -0.0276 (Sell), Stochastic %K stands at 47.826, Stochastic %D stands at 50.725 and CCI stands at -52.705.
GRCE trades below the 60-day SMA (2.26) and below the 200-day SMA (3.09). Immediate resistance sits at Classic R1 2.24, then R2 2.33. Support sits at Classic S1 2.07, then S2 1.99.
Grace Therapeutics, Inc (GRCE) Support & Resistance Level
Grace Therapeutics, Inc (GRCE) Technical Indicators
2026-08-29
| Name | Value |
|---|---|
| RSI_14 | 45.390 |
| STOCHk_14_3_3 | 47.826 |
| STOCHd_14_3_3 | 50.725 |
| CCI_20 | -52.705 |
| AO_5_34 | -0.063 |
| MOM_10 | 0.010 |
| MACD_12_26_9 | -0.028 |
Grace Therapeutics, Inc (GRCE) Relative Strength Index (RSI_14) is 45.390, creating a Neutral signal.
Grace Therapeutics, Inc (GRCE) Stochastic %K is 47.826, creating a Neutral signal.
Grace Therapeutics, Inc (GRCE) Stochastic %D is 50.725, creating a Neutral signal.
Grace Therapeutics, Inc (GRCE) CCI_20 is -52.705, creating a Neutral signal.
Grace Therapeutics, Inc (GRCE) Awesome Oscillator (AO) is -0.063, creating a Sell signal.
Grace Therapeutics, Inc (GRCE) Momentum (MOM) is 0.010, creating a Buy signal.
Grace Therapeutics, Inc (GRCE) Moving Average Convergence Divergence (MACD) is -0.028, creating a Sell signal.
Grace Therapeutics, Inc (GRCE) Moving Average
2026-08-29
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 2.140 | Sell |
| MA_10 | 2.162 | Sell |
| MA_20 | 2.143 | Sell |
| MA_60 | 2.264 | Sell |
| MA_200 | 3.090 | Sell |
| MA_250 | 3.091 | Sell |
Grace Therapeutics, Inc (GRCE) 5-Day simple moving average is 2.140, while Grace Therapeutics, Inc (GRCE) share price is $, making it a Sell.
Grace Therapeutics, Inc (GRCE) 10-Day simple moving average is 2.162, while Grace Therapeutics, Inc (GRCE) share price is $, making it a Sell.
Grace Therapeutics, Inc (GRCE) 20-Day simple moving average is 2.143, while Grace Therapeutics, Inc (GRCE) share price is $, making it a Sell.
Grace Therapeutics, Inc (GRCE) 60-Day simple moving average is 2.264, while Grace Therapeutics, Inc (GRCE) share price is $, making it a Sell.
Grace Therapeutics, Inc (GRCE) 200-Day simple moving average is 3.090, while Grace Therapeutics, Inc (GRCE) share price is $, making it a Sell.
Grace Therapeutics, Inc (GRCE) 250-Day simple moving average is 3.091, while Grace Therapeutics, Inc (GRCE) share price is $, making it a Sell.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.